Cite
HARVARD Citation
Joseph‐Mathurin, N. et al. (2022). Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease. Annals of neurology. 92 (5), pp. 729-744. [Online].